Clinical Trial Update: Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating Hansenula-derived Pegylated Interferon for chronic hepatitis C, with no disclosed update on the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Hansenula-derived Pegylated Interferon (Pegylated interferon alfa)

Snippet

Sponsor: MinaPharm Pharmaceuticals | Conditions: Chronic Hepatitis C | Phase 4 | Status: UNKNOWN